Elevated serum adenosine deaminase levels in neuroleptic-naïve patients with recent-onset schizophrenia

Abstract

The present study examined serum levels of adenosine deaminase (ADA), an adenosine metabolizing enzyme, in neuroleptic-naive patients with recent-onset schizophrenia and age-matched healthy comparison subjects. ADA levels were found to be higher among patients, and revealed a possible link between evening rise and severity of auditory hallucinations as well as morning rise and severity of avolition-apathy in patients with schizophrenia. These findings suggest the potential utility of serum ADA as a peripheral biomarker of schizophrenia.

Keywords: Adenosine deaminase; Avolition; Hallucination; Neuroleptic-naive; Schizophrenia.